Ospemifene 60 mg Tablet, Film Coated — NDC 63069-601-02 (Billing 63069-0601-02)
This is a package of Ospemifene 60 mg Tablet, Film Coated from PENN PHARMACEUTICAL SERVICES LTD, first listed with the FDA Feb 2013 and currently FDA-listed.
NDC database record
One package, one record: these facts belong to NDC 63069-601-02 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 63069 labeler · 601 product · 02 package
- Package marketed since
- Feb 26, 2013
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 6306960102 2
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 19, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats moderate to severe painful sex and moderate to severe vaginal dryness caused by menopause. Both are symptoms of vulvar and vaginal atrophy. The brand is Osphena, and it i...
- Take one tablet by mouth once a day with food. Food helps your body absorb the medicine. Your prescriber should use it for the shortest time that makes sense for you and recheck wh...
- The most common ones are hot flashes, vaginal discharge, muscle spasms, headache, sweating and night sweats. Some women have vaginal bleeding. Call your doctor about any unexplaine...
- Osphena can raise the risk of stroke, blood clots and uterine cancer. Get emergency help for sudden weakness, trouble speaking, chest pain, shortness of breath, or leg pain or swel...
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Ospemifene — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 19, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 63069-0601-01 63069-601-01 Main listing | 600 BLISTER PACK in 1 CARTON / 15 TABLET, FILM COATED in 1 BLISTER PACK | — | — | Active |
| 63069-0601-02 You're viewing this | 1250 BLISTER PACK in 1 CARTON / 5 TABLET, FILM COATED in 1 BLISTER PACK | — | — | Active |
| 63069-0601-03 63069-601-03 | 1 BAG in 1 CONTAINER / 30000 TABLET, FILM COATED in 1 BAG | — | — | Active |
Pack size FAQ
What quantity is in this package?
What NDC number is used to bill for this package of Ospemifene 60 mg Tablet, Film Coated?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Osphena 60 mg 55494-0580-18 | Duchesnay | 15 tablets | — | — | FDA listed | — |
| Ospemifene 60 mgthis 63069-0601-02 | PENN | 5 tablets | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Ospemifene inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 19, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from PENN PHARMACEUTICAL SERVICES LTD labeler code 63069
- larotrectinib 100 mg Capsule NDC 63069-391-01
- larotrectinib 20 mg/mL Liquid NDC 63069-392-01
- pomalidomide 2 mg Capsule NDC 63069-402-00
- pomalidomide 3 mg Capsule NDC 63069-403-00
- pomalidomide 4 mg Capsule NDC 63069-404-00
- FENFLURAMINE HYDROCHLORIDE 2.2 ug/mL Solution NDC 63069-525-30
- Vandetanib 100 mg Tablet, Film Coated NDC 63069-782-03
- Vandetanib 300 mg Tablet, Film Coated NDC 63069-784-03
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: PENN PHARMACEUTICAL SERVICES LTD supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |